TheraTarget is located in Salt Lake City, Utah, and was incorporated as a spin-off company from the University of Utah through the USTAR Initiative, and it based on the expertise and technologies of Drs. Jindrich Kopecek and Hamid Ghandehari, who are professors of pharmaceutics and bioengineering at the University of Utah, and Dr. Chang Ahn who is world-renown for his drug development expertise. Company is an emerging biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies.